Intellia Therapeutics Aktie
19,51
EUR
-3,00
EUR
-13,31
%
24,98
USD
+0,25
USD
+1,01
%
Werbung
Intellia Therapeutics Aktie Analyse
02.11.18 | Intellia Therapeutics Neutral | Wedbush Morgan Securities Inc. | |
15.05.18 | Intellia Therapeutics Buy | Chardan Capital Markets | |
28.03.17 | Intellia Therapeutics Buy | Chardan Capital Markets | |
31.05.16 | Intellia Therapeutics Outperform | Wedbush Morgan Securities Inc. |
Werbung
Werbung